The anti-aging market has skyrocketed from a mere $3 billion in 1989 to an estimated $63 billion in 2021, with projections indicating continued growth. While there’s a call for more robust research, the lack of incentive for pharmaceutical companies to publish findings reveals a tension between profit and public health. The conversation highlights the stark difference between the urgency of acne treatments and the more superficial focus on wrinkles, questioning the allocation of research funding in a capitalist framework.
